HIV DART 2024 Hannah N. Wilkins 1/9/25 HIV DART 2024 Hannah N. Wilkins 1/9/25 The Blood Brain Barrier Demonstrates Capability to Influence Heterogenous Tenofovir and Emtricitabine Metabolism and Transport in the Brain Read More HIV DART 2024 Namuli S 1/9/25 HIV DART 2024 Namuli S 1/9/25 HIV associated factors among adult individuals during the treat all era at health centres in Uganda Read More HIV DART 2024 Ndiana-Abasi Peter 1/9/25 HIV DART 2024 Ndiana-Abasi Peter 1/9/25 Effect Of Polypharmacy On Medication Adherence In Geriatrics Persons Above 50 Years Living With Hiv In Southern Nigeria Read More HIV DART 2024 Sana Musa 1/9/25 HIV DART 2024 Sana Musa 1/9/25 HIV pre-exposure prophylaxis (PrEP) to improve access Read More HIV DART 2024 M Murombo 1/9/25 HIV DART 2024 M Murombo 1/9/25 ‘Darling I’m looking out for my well being’: Unpacking the Stigma that Hinders Married African Women from Embracing PrEP for HIV Prevention Read More HIV DART 2024 Lauren Middlebrooks 1/9/25 HIV DART 2024 Lauren Middlebrooks 1/9/25 Human Immunodeficiency Virus Opt-out Testing Increases Syphilis Screening in Pediatric Emergency Departments Read More HIV DART 2024 Alexxis Leyva 1/9/25 HIV DART 2024 Alexxis Leyva 1/9/25 Using Natural Language Processing to Examine Stigmatizing Language in Electronic Health Care Records among Latinx Sexual Minorities Read More HIV DART 2024 Irina Kolobova 1/9/25 HIV DART 2024 Irina Kolobova 1/9/25 High real-world adherence with long-acting cabotegravir plus rilpivirine (CAB+RPV LA) among people with HIV (PWH) in the United States (US) Read More HIV DART 2024 Wokovu Nibron Kitule 1/9/25 HIV DART 2024 Wokovu Nibron Kitule 1/9/25 Empowering Women Living with HIV: Nutritional Interventions and Inclusive Support for Vulnerable Communities Read More HIV DART 2024 Marie Lina Excellent 1/9/25 HIV DART 2024 Marie Lina Excellent 1/9/25 Enhancing HIV Awareness via HIV Self-Testing in Community Contexts: Perspectives and Guidance for Haiti’s National AIDS Control Program within the Ministry of Health Read More HIV DART 2024 John Boulos 1/9/25 HIV DART 2024 John Boulos 1/9/25 Comparative outcomes analysis from randomized clinical trials of dolutegravir/lamivudine and tenofovir alafenamide–based antiretroviral regimens among US participants Read More HIV DART 2024 Nelly Belledent 1/9/25 HIV DART 2024 Nelly Belledent 1/9/25 A Rapid Access Test and Treat Program to Reduce HIV Transmission in Miami-Dade County Read More HIV DART 2024 Julio Aliberti 1/9/25 HIV DART 2024 Julio Aliberti 1/9/25 The NIH OAR Data Hub: Enhancing Information Dissemination of the NIH HIV Research Portfolio Read More HIV DART 2024 Marie Lina Excellent 12/24/24 HIV DART 2024 Marie Lina Excellent 12/24/24 Enhancing the accessibility of HIV-testing services (HTS) for vulnerable and hard-to-reach men through outreach initiatives by regional male-friendly clinics… Read More HIV DART 2024 Alftan Dyson 12/24/24 HIV DART 2024 Alftan Dyson 12/24/24 Positive Impact of Fostemsavir in Individuals With a Viral Load <40 and <400 Copies/mL With Limited Treatment Options Through Week 192 Read More HIV DART 2024 Marie Armani-Tourret 12/24/24 HIV DART 2024 Marie Armani-Tourret 12/24/24 Selection of epigenetically privileged HIV-1 proviruses during treatment with HDACi and IFN-α2a Read More HIV DART 2024 Paula Cevaal 12/24/24 HIV DART 2024 Paula Cevaal 12/24/24 Leveraging mRNA and lipid nanoparticle technology to develop a cure for HIV Read More HIV DART 2024 Scott Letendre 12/22/24 HIV DART 2024 Scott Letendre 12/22/24 Clinical Trials to Treat Brain Health Disorders in Persons with HIV Read More HIV DART 2024 Avi Nath 12/22/24 HIV DART 2024 Avi Nath 12/22/24 HIV and the Nervous System: Biotypes and viral persistence Read More HIV DART 2024 Ronald Desrosiers 12/22/24 HIV DART 2024 Ronald Desrosiers 12/22/24 Long-term Continuous Delivery of Anti-HIV Monoclonal Antibodies Using AAV Vector Read More Older Posts
HIV DART 2024 Hannah N. Wilkins 1/9/25 HIV DART 2024 Hannah N. Wilkins 1/9/25 The Blood Brain Barrier Demonstrates Capability to Influence Heterogenous Tenofovir and Emtricitabine Metabolism and Transport in the Brain Read More
HIV DART 2024 Namuli S 1/9/25 HIV DART 2024 Namuli S 1/9/25 HIV associated factors among adult individuals during the treat all era at health centres in Uganda Read More
HIV DART 2024 Ndiana-Abasi Peter 1/9/25 HIV DART 2024 Ndiana-Abasi Peter 1/9/25 Effect Of Polypharmacy On Medication Adherence In Geriatrics Persons Above 50 Years Living With Hiv In Southern Nigeria Read More
HIV DART 2024 Sana Musa 1/9/25 HIV DART 2024 Sana Musa 1/9/25 HIV pre-exposure prophylaxis (PrEP) to improve access Read More
HIV DART 2024 M Murombo 1/9/25 HIV DART 2024 M Murombo 1/9/25 ‘Darling I’m looking out for my well being’: Unpacking the Stigma that Hinders Married African Women from Embracing PrEP for HIV Prevention Read More
HIV DART 2024 Lauren Middlebrooks 1/9/25 HIV DART 2024 Lauren Middlebrooks 1/9/25 Human Immunodeficiency Virus Opt-out Testing Increases Syphilis Screening in Pediatric Emergency Departments Read More
HIV DART 2024 Alexxis Leyva 1/9/25 HIV DART 2024 Alexxis Leyva 1/9/25 Using Natural Language Processing to Examine Stigmatizing Language in Electronic Health Care Records among Latinx Sexual Minorities Read More
HIV DART 2024 Irina Kolobova 1/9/25 HIV DART 2024 Irina Kolobova 1/9/25 High real-world adherence with long-acting cabotegravir plus rilpivirine (CAB+RPV LA) among people with HIV (PWH) in the United States (US) Read More
HIV DART 2024 Wokovu Nibron Kitule 1/9/25 HIV DART 2024 Wokovu Nibron Kitule 1/9/25 Empowering Women Living with HIV: Nutritional Interventions and Inclusive Support for Vulnerable Communities Read More
HIV DART 2024 Marie Lina Excellent 1/9/25 HIV DART 2024 Marie Lina Excellent 1/9/25 Enhancing HIV Awareness via HIV Self-Testing in Community Contexts: Perspectives and Guidance for Haiti’s National AIDS Control Program within the Ministry of Health Read More
HIV DART 2024 John Boulos 1/9/25 HIV DART 2024 John Boulos 1/9/25 Comparative outcomes analysis from randomized clinical trials of dolutegravir/lamivudine and tenofovir alafenamide–based antiretroviral regimens among US participants Read More
HIV DART 2024 Nelly Belledent 1/9/25 HIV DART 2024 Nelly Belledent 1/9/25 A Rapid Access Test and Treat Program to Reduce HIV Transmission in Miami-Dade County Read More
HIV DART 2024 Julio Aliberti 1/9/25 HIV DART 2024 Julio Aliberti 1/9/25 The NIH OAR Data Hub: Enhancing Information Dissemination of the NIH HIV Research Portfolio Read More
HIV DART 2024 Marie Lina Excellent 12/24/24 HIV DART 2024 Marie Lina Excellent 12/24/24 Enhancing the accessibility of HIV-testing services (HTS) for vulnerable and hard-to-reach men through outreach initiatives by regional male-friendly clinics… Read More
HIV DART 2024 Alftan Dyson 12/24/24 HIV DART 2024 Alftan Dyson 12/24/24 Positive Impact of Fostemsavir in Individuals With a Viral Load <40 and <400 Copies/mL With Limited Treatment Options Through Week 192 Read More
HIV DART 2024 Marie Armani-Tourret 12/24/24 HIV DART 2024 Marie Armani-Tourret 12/24/24 Selection of epigenetically privileged HIV-1 proviruses during treatment with HDACi and IFN-α2a Read More
HIV DART 2024 Paula Cevaal 12/24/24 HIV DART 2024 Paula Cevaal 12/24/24 Leveraging mRNA and lipid nanoparticle technology to develop a cure for HIV Read More
HIV DART 2024 Scott Letendre 12/22/24 HIV DART 2024 Scott Letendre 12/22/24 Clinical Trials to Treat Brain Health Disorders in Persons with HIV Read More
HIV DART 2024 Avi Nath 12/22/24 HIV DART 2024 Avi Nath 12/22/24 HIV and the Nervous System: Biotypes and viral persistence Read More
HIV DART 2024 Ronald Desrosiers 12/22/24 HIV DART 2024 Ronald Desrosiers 12/22/24 Long-term Continuous Delivery of Anti-HIV Monoclonal Antibodies Using AAV Vector Read More